INTS vs MOS
Intensity Therapeutics, Inc. Common stock (INTS) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
INTS currently screens at market cap $7.7M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the INTS and MOS stock pages for the full models.
Not investment advice.